Kristen Fortney - Chief Executive Officer, Director at BioAge Labs, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
BIOA on Nasdaq
All Insider Reports
All Insider Reports

Kristen Fortney - trading volume in the past year for BioAge Labs, Inc.

Holdings reported by Kristen Fortney for BioAge Labs, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 976,949 $17,698,701 $18.12 13 Jan 2026 Direct
Stock Option (Right to Buy) 330,000 17 Feb 2026 Direct Common Stock

Transactions reported by Kristen Fortney for BioAge Labs, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.